# Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

> **NCT07483658** · NA · NOT_YET_RECRUITING · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 434 (estimated)

## Conditions studied

- Reccurent/Metastatic Solid Tumor Disease
- Prostate Cancer (Post Prostatectomy)
- Prostate Cancer
- Prostatic Neoplasms
- Neoplasm Recurrence, Local
- Biochemical Recurrence of Malignant Neoplasm of Prostate

## Interventions

- **RADIATION:** Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions)
- **RADIATION:** Hypofractionated Post-Operative Salvage Radiotherapy (20 fractions)
- **DRUG:** Androgen Deprivation Therapy (ADT)

## Key facts

- **NCT ID:** NCT07483658
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2029-12
- **Final completion:** 2036-02
- **Target enrollment:** 434 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07483658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07483658, "Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07483658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*